Wanjia Group Holdings Limited (HKG:0401)

Market Cap	58.82M +36.4%
Revenue (ttm)	163.70M -4.5%
Net Income	-8.58M
EPS	-0.02
Shares Out	560.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	534,408
Average Volume	933,106
Open	0.1100
Previous Close	0.1060
Day's Range	0.1050 - 0.1140
52-Week Range	0.0490 - 0.1820
Beta	1.37
RSI	46.27
Earnings Date	Feb 16, 2026

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloo...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 177
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0401

Financial Performance

In fiscal year 2025, Wanjia Group Holdings's revenue was 161.69 million, a decrease of -10.71% compared to the previous year's 181.09 million. Losses were -6.62 million, -83.45% less than in 2024.